Velocity Clinical Research-Seattle — Seattle, Washington

Velocity Clinical Research-Seattle is a clinical research site located in Seattle, Washington, United States 98105.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

Velocity Clinical Research-Seattle has participated in 9 clinical trials with 7 currently active.

Therapeutic areas: Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis.

Sponsors: Boehringer Ingelheim, CSL Behring, Sanofi Pasteur, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seattle

Browse all research sites in Washington · View every site in Seattle

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research-Seattle?

Velocity Clinical Research-Seattle has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research-Seattle conducted?

Velocity Clinical Research-Seattle has 9 clinical trials on record, with 7 currently active. Their work covers Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis.

Is Velocity Clinical Research-Seattle accredited by Crixeo Clinical Trials?

Velocity Clinical Research-Seattle has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research-Seattle?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.